India Pharma · Doctor-Facing HCP Education Platforms · Competitive Analysis

What Indian Pharma Has Actually Built for Doctors

A comparative review of owned, doctor-facing HCP education and engagement platforms. Focused on platforms doctors log into directly — not field force tools or eDetailing systems.

✓ All facts sourced and labelled — Public source or Company-disclosed. Nothing assumed.
4 Doctor-Facing Platforms April 2026 Verified + Company-Disclosed Data Gap Analysis Included
Data Key:
Public — verifiable public source (press release, app store, case study)
Company — disclosed by MediSamvad/Alkem project team; not independently published
N/D — not publicly disclosed
The Numbers

Registered Doctor Base — What's Known

This is the most-asked question in any platform comparison — and the one most companies refuse to answer publicly.

CiplaMed · Cipla
1,00,000+
Registered HCPs
✓ Public — Google Play Store listing
Docflix · Mankind
Not Disclosed
No public figure available
— Not in any public source
DRL HCP Portal · Dr Reddy's
Not Disclosed
No public figure available
— Not in any public source
MediSamvad · Alkem
1,80,000+
Registered doctors (as of Apr 2026)
◆ Company-disclosed · MediSamvad project team

Note: CiplaMed's figure is from the Google Play app listing (app downloads ≠ total platform users, which may be higher including web). MediSamvad's 1,80,000+ figure covers the period from public launch (Dec 2024 press) through April 2026 and is company-disclosed. Docflix and DRL have not published any HCP count in any public source.

Platform Profiles

What Each Platform Actually Offers

Doctor-facing platforms only. Cipla Assist (field force content delivery tool) is noted separately at the end — it is a different category.

Cipla
CiplaMed + CiplaMed Flix
India's oldest brand-owned HCP medical portal — unbiased, evidence-based content across specialties. A separate CME app (CiplaMed Flix) runs alongside it.
Pioneer · ~2014 onwards
Registered HCPs
1,00,000+
✓ Google Play listing
Specialties
18–19
✓ ciplamed.com + Play Store
Access
Web + iOS + Android
✓ App stores confirmed
Current Version
CiplaMed 2.0
✓ BioVoiceNews, Aug 2023
  • Public eCME, guideline infographics, podcasts, expert videos, journal article highlights, international conference highlights, patient education materials — Google Play listing
  • Public Community section, Quick Reads, Events & Videos, Product Index, Conference Highlights, Guidelines — from ciplamed.com navigation
  • Public Content explicitly "unbiased" — goes beyond Cipla's own portfolio — ciplamed.com About page
  • Public CiplaMed Flix (separate app): High-value CMEs by Healthcare Superstars (HSS) in multiple languages, KOL content, premium articles & presentations, new launch discovery, conference highlights with language selection, Content Interest Feature (personalise feed) — Apple App Store
  • Public CiplaMed 2.0: advanced analytics and automation — BioVoiceNews, Aug 2023
  • N/D Field force integration, CME accreditation body name, engagement metrics, prescription attribution
Differentiator
Only platform with a two-product strategy publicly confirmed: CiplaMed for clinical reference, CiplaMed Flix for CME/KOL content consumption. "Unbiased" content (beyond Cipla's own portfolio) is an explicit and distinctive positioning. Largest publicly confirmed HCP base at 1,00,000+.
Mankind Pharma
Docflix
India's first OTT-format doctor education platform — scientific content produced like a show, not a slide deck.
Launched May 2022
Registered HCPs
Not disclosed
— No public figure
App Store Rating
4.8 / 5
✓ Apple App Store India (110 ratings)
Access
iOS + Android
✓ Both app stores confirmed
CME Accreditation
Not offered
✓ Absent from all public sources
  • Public OTT video platform — Medical Guidelines, Doctor Conferences, News, Expert Views sections — Google Play & App Store listing
  • Public AI-driven personalisation confirmed live in app store description — Google Play + App Store
  • Public Doctor avatars, peer chat / interaction between doctors, explore peer profiles and contributed content — Softonic/app description
  • Public Named shows: Science Simplified, Legend Inside the White Coat, Stitch in Time, Cardio Unflip, Digital for Doctors, Medico-legal Cases in India, Vantage Point — multiple press sources
  • Public NID-trained designers, scriptwriters and directors produce content — IndianTelevision, MedDialogues, May 2022
  • Public Content from trusted publishing partners + senior cardiologists — app store listing
  • N/D HCP count, active user metrics, field force integration, CME credits, engagement data
Differentiator
Format innovation — only platform where AI personalisation, peer chat and doctor avatars are confirmed live features from public app store listings (not just launch claims). Entertainment-grade production (NID, scriptwriters, directors) is a category-of-one. However: no CME accreditation, no published HCP count.
Dr. Reddy's Laboratories
DRL HCP Engagement Portal
A globally architected, multilingual DXP — the most technically documented HCP platform built by any Indian pharma company.
Built in <7 months · 2022
Registered HCPs
Not disclosed
— No public figure
Tech Stack
Drupal 9 + Acquia SF
✓ QED42 + Drupal.org case study
Country Sites
20+ countries
✓ QED42 case study
CRM Integration
IQVIA OCE
✓ IQVIA + DRL press release, Sep 2022
  • Public Dual interface: text-based content mode AND video-based mode with intuitive toggle — QED42 + Drupal.org case study
  • Public Personalized weekly email recommendations to HCPs — QED42 case study
  • Public Personalized onboarding tailored by HCP specialty and demographics — QED42 case study
  • Public Multilingual, geo-specific compliance baked into architecture across 20+ country sites (India, Brazil, Colombia named) — QED42 + Acquia case study
  • Public Acquia Search for content discovery — Acquia case study
  • Public Centralized content hub — single-source publish to all country sites — QED42 case study
  • Public IQVIA OCE deployed to entire India field force under multi-year agreement — near real-time in-clinic and field analytics — IQVIA/DRL joint press release, Sep 2022
  • Public API-certified e-Hypertension Academy documented — publicly referenced CME programme
  • N/D Registered HCP count, engagement metrics, prescription attribution outcomes
Differentiator
Most technically sophisticated and most thoroughly documented platform in the market. Two facts set it uniquely apart: (1) 20+ country geo-compliant architecture — no other Indian pharma has published this, (2) IQVIA OCE across entire India field force under a confirmed multi-year deal — the only company with a publicly confirmed closed digital + field loop.
Alkem Laboratories
MediSamvad
Alkem's owned HCP education and engagement platform — publicly launched December 2024, with a broader feature set than the press coverage captured.
Launched Dec 2024 (Press) · Live from Oct 2024
Registered Doctors
1,80,000+
◆ Company-disclosed · Apr 2026
Platform Age
~18 months
✓ Dec 2024 press · Oct 2024 go-live
Access
Web portal
✓ Launch coverage; no app announced
CME
Webinar portal
✓ Confirmed in launch press
  • Public Research articles, case studies, clinical guidelines, global medical advancements — launch press: BioSpectrum, eHealth, BioVoiceNews, IndiaMedToday (Dec 2024)
  • Public Dedicated web portal for CME webinars and peer community interaction — launch press
  • Public User-friendly interface for seamless access to practice-oriented content — launch coverage
  • Company Large-scale KOL-led webinars hosted on platform — company-disclosed
  • Company RTMs (Round Table Meetings) conducted via platform — company-disclosed
  • Company AdBoards (Advisory Board meetings) conducted via platform — company-disclosed
  • Company Conference simulcasts — live streaming of major medical conferences to registered doctors — company-disclosed
  • Company ISPs (International Symposia Programs) and large-scale simulcasts — company-disclosed
  • Company Medical association events hosted — including specialty society doctor communities — company-disclosed
  • Company AI Chatbot available to registered doctors on the platform — company-disclosed
  • N/D Field force integration (not publicly confirmed), multilingual support, mobile app, CME accreditation body name
Differentiator
Fastest-growing platform in this comparison — 1,80,000+ registered doctors in ~18 months vs CiplaMed's 1,00,000+ over ~10 years (noting these are different measurement methods). The feature depth — RTMs, AdBoards, conference simulcasts, ISPs, association events, and a chatbot — goes significantly beyond a knowledge portal and into a full HCP engagement infrastructure. This breadth is not publicly documented and represents an undercommunicated competitive advantage.
⚑ Note: Cipla Assist — A Different Category
Cipla Assist is a field force content delivery tool — the Cipla field team accesses it, and content is delivered to their mapped doctors via the rep. This is a fundamentally different model from the doctor-facing platforms above (where the doctor logs in directly). It falls in the eDetailing / CLM (Closed Loop Marketing) category, not the HCP education portal category, and is therefore not compared here. CLIRNET has created content for Cipla Assist — though this is not published in any public source.
Feature Comparison

Platform Feature Matrix

Side-by-side comparison of all documented features. Sources labelled for every cell.

Feature / Parameter CiplaMed (Cipla) Docflix (Mankind) DRL Portal MediSamvad (Alkem)
Platform Fundamentals
Doctor Access Model Direct login — doctor-facing web + app Direct login — doctor-facing app Direct login — doctor-facing web portal Direct login — doctor-facing web portal
Launch Year ~2014; v2.0 Aug 2023 Public May 2022 Public 2022 Public Dec 2024 (press) Public
Registered Doctors 1,00,000+ Public Not disclosed Not disclosed 1,80,000+ Company
Web Access ✓ Public ✗ App-only ✓ Public ✓ Public
Mobile App (iOS) ✓ CiplaMed + CiplaMed Flix Public ✓ 4.8 rating / 110 reviews Public Not confirmed publicly ✗ Not announced
Mobile App (Android) ✓ CiplaMed app Public ✓ Confirmed Public Not confirmed publicly ✗ Not announced
Content Formats
Clinical Articles / Guidelines ✓ Journal highlights, guidelines Public ◐ Via shows (Medical Guidelines section) ✓ Text content confirmed Public ✓ Research articles, case studies, guidelines Public
Expert / KOL Videos ✓ Expert videos confirmed Public ✓ Core format — all content is video Public ✓ Video interface confirmed Public ✓ KOL-led large webinars Company
Podcasts ✓ Confirmed Public Not confirmed Not confirmed Not confirmed
Infographics ✓ Guideline infographics confirmed Public Not confirmed separately Not confirmed Not confirmed
Conference Highlights ✓ International conference highlights Public ✓ Doctor conferences section Public Not confirmed ✓ Live simulcasts of major conferences Company
Patient Education Materials ✓ Confirmed Public Not confirmed Not confirmed Not confirmed
Live Engagement Formats
CME Webinars ✓ eCME confirmed Public ✗ No CME format announced ✓ API-certified programme confirmed Public ✓ Dedicated webinar portal Public
Large-Scale KOL Webinars Not specified Not specified Not specified ✓ Company
RTMs (Round Table Meetings) Not confirmed Not confirmed Not confirmed ✓ Company
AdBoards (Advisory Boards) Not confirmed Not confirmed Not confirmed ✓ Company
Conference Simulcasts (Live) Not confirmed Not confirmed Not confirmed ✓ Company
ISPs / International Symposia Not confirmed Not confirmed Not confirmed ✓ Large-scale simulcasts Company
Medical Association Events Not confirmed Not confirmed Not confirmed ✓ Specialty society communities hosted Company
Technology & Personalisation
AI Personalisation ◐ Referenced in v2.0; depth unverified Public ✓ AI-driven personalisation — confirmed live in app store Public ✓ Behaviour-based reco + weekly email engine Public Not confirmed publicly
Chatbot for Doctors Not confirmed Not confirmed Not confirmed ✓ Available to registered doctors Company
Peer Interaction / Community ✓ Community section confirmed Public ✓ Peer chat, avatars, profile exploration Public Not specified ✓ Peer community via webinar portal Public
Multilingual Content ◐ CiplaMed Flix: CME in multiple languages Public Not confirmed ✓ 20+ country geo-compliant multilingual Public Not confirmed publicly
Field Force Integration Not confirmed publicly Not confirmed publicly ✓ IQVIA OCE — entire India FF, multi-year deal Public Not confirmed publicly
Analytics / Reporting ◐ Advanced analytics claimed in v2.0 Public Not disclosed ✓ User behaviour + IQVIA real-time in-clinic analytics Public Not confirmed publicly
Named CME Accreditation Body ✗ eCME offered but body unnamed publicly ✗ No CME at all ✓ API-certified programme confirmed Public ◐ CME webinar portal confirmed; body not named Public
First-Party Data (Owned) ✓ Owned platform ✓ Owned platform ✓ Owned platform + IQVIA layer ✓ Owned platform
Prescription Attribution Not mentioned publicly Not mentioned publicly IQVIA enables this — not publicly claimed Not mentioned publicly

Public = verifiable independent source  |  Company = disclosed by MediSamvad/Alkem project team; not independently published  |  ✓ Yes  |  ◐ Partial / Claimed  |  ✗ No  |  Blank = Not confirmed in any source

Industry Gap Analysis

What the Entire Category Hasn't Solved

Based on what is documented — and what is conspicuously absent — across all four platforms.

Gap 01
No Platform Publishes Verified Engagement Data
CiplaMed is the only platform with a public HCP count (1L+, from app store). Docflix and DRL publish nothing. MediSamvad's 1.8L figure is company-disclosed, not independently published. There is no industry standard, no audit, no independent verification of "active" vs "registered" doctors anywhere in this market. Every pharma client making a platform decision is doing so blind.
Opportunity for MediSamvadPublishing the 1,80,000+ figure with a clear date and methodology — even in a press release or annual report — would make it the most transparent platform in the market overnight.
Gap 02
The Content → Prescription Attribution Loop Remains Unproven
No platform has publicly demonstrated the chain: doctor engaged with content → field rep was informed → prescription behaviour shifted. DRL + IQVIA OCE has the infrastructure for it but hasn't published outcomes. This is the single question every pharma commercial head wants answered, and every platform dodges it.
OpportunityEven a division-level case study showing engagement-to-sales movement would be the most commercially compelling story in Indian pharma digital health.
Gap 03
Regional Language — The Biggest Accessibility Failure
CiplaMed Flix offers CME in multiple languages (app store). DRL is multilingual for global markets. But India's Tier 2-3 doctor — who represents the majority of practising physicians — is being served in English by all four platforms. No platform has made regional language delivery a confirmed India strategy. This is not a feature gap; it is a relevance gap.
OpportunityAny platform that confirms Hindi or one regional language as a content delivery channel becomes the first to address the largest underserved HCP segment in the country.
Gap 04
CME Accreditation Transparency is Universally Poor
CiplaMed offers eCME but names no accrediting body publicly. DRL names one API-certified programme. Docflix offers no CME at all. MediSamvad has a CME webinar portal but names no accrediting body. A doctor considering whether to spend time on a platform for CME credits needs to know the body, the credit structure, and the recognition. None of the platforms communicate this clearly.
OpportunityPublishing the accreditation body name and credit structure on the platform is a zero-cost upgrade that immediately improves doctor trust and time investment.
Gap 05 — The Strategic Gap
MediSamvad's Real Capabilities Are Almost Entirely Undercommunicated
The public record for MediSamvad — research articles, case studies, webinars — dramatically undersells what the platform actually does. RTMs, AdBoards, conference simulcasts, ISPs, association events, a chatbot, 1.8 lakh doctors — none of this is in the public domain. The result: in any external competitive comparison, MediSamvad appears as a basic knowledge portal launched in December 2024, when it is actually a full-scale HCP engagement infrastructure with a doctor base larger than CiplaMed's publicly stated figure. The gap between what MediSamvad is and what the market knows it is — is the biggest immediate opportunity.
Recommended ActionA single well-written press release or industry article covering the platform's actual feature set, 1.8L doctor milestone, event formats hosted, and association partnerships would reposition MediSamvad from "new entrant" to "largest HCP engagement platform among Indian pharma owned properties." This story is waiting to be told.
MediSamvad · Competitive Position

Where MediSamvad Stands vs. the Competition

Based on combined public and company-disclosed data. Company-disclosed items marked.

Established Leader
CiplaMed (Cipla)
Registered HCPs
1,00,000+ (public)
Platform Age
~10+ years
Live Formats
eCME, webinars (inferred)
Chatbot
Not confirmed
Biggest Edge
Scale + unbiased brand + dual app
Format Innovator
Docflix (Mankind)
Registered HCPs
Not disclosed
Platform Age
3 years (2022)
Live Formats
No CME / no live events
Chatbot
Not confirmed
Biggest Edge
OTT format + AI + peer chat
Tech Leader
DRL Portal
Registered HCPs
Not disclosed
Platform Age
3 years (2022)
Live Formats
API-certified CME confirmed
Chatbot
Not confirmed
Biggest Edge
Global DXP + IQVIA FF loop
Full-Stack Engagement Platform
MediSamvad (Alkem)
Registered Doctors
1,80,000+ ◆
Platform Age
~18 months
Live Formats
Webinars, RTMs, AdBoards, Simulcasts, ISPs ◆
Chatbot
✓ Confirmed ◆
Biggest Gap
Story not told publicly
The Way Forward for MediSamvad